"Innovative Market Solutions to Help Businesses Make Informed Decisions"
Thymoquinone is a phytochemical that is found in plant like Nigella sativa (black cumin) and Monarda fistulosa. Essential oil containing thymoquinone is steam distilled from the plant Monarda fistulosa that is cultivated in the states of U.S. the chemical shows anti-inflammatory and anti-oxidant properties when experimented on animal cells. It is also studied in models of cardiovascular diseases, diabetes, cancer, neurodegenerative diseases and others. It has been classified as a pan-assay interference compound which indiscriminately binds to all proteins.
Increasing demand for therapeutic drugs that can cure cancer, arthritis, and cardiovascular disease is boosting the demand for thymoquinone. Additionally, the increasing R&D in the anti-carcinogenic drug and ingredients is expected to positively impact the market growth. Thymoquinone is also a superoxide scavenger which preserves the activity of various anti-oxidant enzymes. This is expected to boost the market growth.
However, thymoquinone may interact with certain medications like beta blockers and warfarins. This is likely to limit the market growth.
Based on purity, the market is segmented into <98%, 98%-99%, >99%, and others. Based on application, the market is segmented into pharmaceutical, chemical, and other applications.
From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Key Market Driver -
Increasing demand from pharmaceutical sector.
Key Market Restraint -
Interaction with certain medications.
The global thymoquinone market consists of global & regional players operating. Some of the key players in the market include TCI, Cayman, Sarchem Labs, Clearsynth, Nanjing Zelang, Guangzhou Howei Chemical, Sigma-Aldrich, Toronto Research Chemicals, LKT Laboratories, Ark Pharm, and others.
The market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest market attributed to the extensive R&D in the pharmaceutical sector. Additionally, the large scale production of Monarda fistulosa for extraction of essential oil containing thymoquinone shall impact the market positively. Asia Pacific is estimated to hold significant share attributed to the easy availability of the raw material nigella sativa. Europe is estimated to show considerable growth attributed to the increasing geriatric population and R&D in pharmaceutical sector. Latin America and Middle East & Africa is expected to show sluggish growth by the end of the forecast period.
To gain extensive insights into the market, Request for Customization
ATTRIBUTES | DETAILS |
By Purity |
|
By Application |
|
By Geography |
|
US +1 833 909 2966 ( Toll Free )